Description
Addendum 2016 to IP 2014, consisting of 89 New Monographs
The Addendum 2016 to Indian Pharmacopoeia 2014 is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Government of India, Ministry of Health & Family Welfare and will be effective from 1st January 2016.
Indian Pharmacopoeia is published in continuing pursuit of the mission of IPC to improve the health of the people through ensuring the quality, safety and efficacy of medicines. The Commission has been receiving significant inputs from regulatory, industrial houses, academic institutions, national laboratories, individual scientists and others. Keeping in view of the common health of the Indian population, IP Addendum 2016 comprises various categories of drugs such as Antiviral, Anticancer, Antibacterial, Antihypertensive, Antidepressant and Analgesic etc.
Indian Pharmacopoeia Commission by including new monographs in this addendum trying to boost public confidence in relation to quality of medicines for domestic and overseas use. Addendum 2016 to IP 2014 incorporates 89 New Monographs consisting of 64 Chemical Monographs, 14 Herbal Monographs, 03 Vaccines and Immunsera for Human use, 03 Radiopharmaceuticals Monographs, 01 Blood Related Products, 04 Biotechnology Products Monographs and 02 General Chapter being included in this addendum. It is assured that this addendum would play a significant role in improving the quality of medicines which in turn promote public health and accelerate the growth and development of Pharma sector.
Addendum 2016 to IP 2014 is effective from 1st January 2016.
Feature of the addendum are as follows:
- Total 89 New Monographs have been added which includes
- 64 Chemical Monographs
- 14 Herbal Monographs
- 03 New Human Vaccines Monographs
- 03 Radiopharmaceutical Monographs
- 01 Blood Related Product
- 04 Biotechnology Products Monographs
- 02 General Chapter
Reviews
There are no reviews yet.